In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Windtree Therapeutics, Inc.

http://www.windtreetx.com/

Latest From Windtree Therapeutics, Inc.

Deal Watch: Graphite Exits Via Reverse Merger With Presbyopia Specialist LENZ

Plus deals involving Abliva/Owl, Selecta/Cartesian, Novo Nordisk/Genevant, AbbVie/Aldeyra and more.

Deal Watch Business Strategies

Jefferies Conference Highlights How Biotech’s Rollercoaster Ride Will Continue Into 2024

Survey shows long-term optimism but fears that 2024 will be another hard slog for those biotechs with dwindling cash resources.

Commercial Companies

Gilead And AbbVie Are Not The Only Ones Re-Thinking CD47 Immunotherapies

CD47 was once seen as one of the hottest properties in immunotherapy, but multiple setbacks have tempered enthusiasm for targeting the ‘don’t eat me’ cell surface protein. I-Mab and Gilead are just two casualties.

Deals Clinical Trials

J&J Saves Cidara’s Flu ‘Drug Cocktail’ From Pipeline Purge

Cidara Therapeutics has been given a lifeline after Johnson & Johnson’s opt-in on its universal flu prevention treatment – though the big pharma is expected to pass it onto a third party.

Deals Infectious Diseases
See All

Company Information

  • Industry
  • Medical Devices
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Pulmonary
  • Biotechnology
    • Large Molecule
    • Drug Discovery Tools
      • ADMET
  • Other Names / Subsidiaries
    • Discovery Labs
UsernamePublicRestriction

Register